环丙基(2-甲氧基苯基)甲酮 | 400614-05-3

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 环丙基(2-甲氧基苯基)甲酮
• 中文别名: 环丙基2-甲氧苯基酮
• 英文名称: cyclopropyl(2-methoxyphenyl)methanone
• 英文别名: Cyclopropyl 2-methoxyphenyl ketone；cyclopropyl-(2-methoxyphenyl)methanone
• CAS: 400614-05-3
• 化学式: C₁₁H₁₂O₂
• 分子量: 176.215
• InChiKey: XOAIYFSKASLHHH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2914509090

反应信息

• 作为反应物：
  描述：

  环丙基(2-甲氧基苯基)甲酮 在 正丁基锂 、 Rh(dppp)SbF₆ 作用下， 以 四氢呋喃 、 正己烷 、 1,2-二氯乙烷 为溶剂， 反应 26.0h， 生成 3-(2-methoxyphenyl)cyclohex-2-enone
  参考文献：
  名称：

  Rh(I)-Catalyzed [5 + 1] Cycloaddition of Vinylcyclopropanes and CO for the Synthesis of α,β- and β,γ-Cyclohexenones

  摘要：

  A cationic Rh(I)-catalyzed [5 + 1] cycloaddition of vinylcyclopropanes and CO has been developed, affording either beta,gamma-cyclohexenones as major products or alpha,beta-cyclohexenones exclusively, under different reaction conditions.

  DOI：

  10.1021/ol2031526
• 作为产物：
  描述：

  2-Methoxyphenylmagnesium bromide 在 2,6-二氯吡啶 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 36.0h， 生成 环丙基(2-甲氧基苯基)甲酮
  参考文献：
  名称：

  通过高价碘氧化环丁醇向环丙基酮的轻度环收缩

  摘要：

  已经开发出碘介导的环丁醇的氧化环收缩。该反应可以在温和且环保的条件下合成各种芳基环丙基酮。反应中可以很好地耐受各种官能团，包括芳族或烷基卤化物，醚，酯，酮，烯烃，甚至醛。这与传统的合成方法相反，在传统的合成方法中，官能团的耐受性通常很差。碘氧化系统的可调性也突出了该方法的实用性。具体而言，将碘（III）试剂与适当的碱结合使用可使反应适应一系列富挑战性的富电子芳烃底物。在此也显示了该反应的简便可扩展性。

  DOI：

  10.1002/adsc.201701237

文献信息

• Calcium receptor antagonist
  申请人：——

  公开号：US20040006130A1

  公开（公告）日：2004-01-08

  A compound of the formula [I] 1 wherein R 1 is optionally substituted aryl group or optionally substituted heteroaryl group; R 2 is optionally substituted C 1-6 alkyl group, C 3-7 cycloalkyl group and the like; R 3 is hydrogen atom, C 1-6 alkyl group, hydroxyl group and the like; R 4 is hydrogen atom, C 1-6 alkyl group and the like; R 5 and R 6 are each C 1-6 alkyl group and the like; R 7 is optionally substituted aryl group or optionally substituted heteroaryl group; X 1 , X 2 and X 3 are each C 1-6 alkylene group and the like; and X 4 and X 5 are each a single bond, methylene group and the like, a salt thereof, a solvate thereof or a prodrug thereof, and a pharmaceutical composition containing the compound, particularly a calcium receptor antagonist and a therapeutic agent for osteoporosis, are provided. The compound of the present invention is useful as a therapeutic drug of diseases accompanied by abnormal calcium homeostasis, or osteoporosis, hypoparathyreosis, osteosarcoma, periodontal disease, bone fracture, steoarthrosis, chronic rheumatoid arthritis, Paget's disease, humoral hypercalcemia, autosomal dominant hypocalcemia and the like. In addition, an intermediate for the compound is provided.

  式为[I]的化合物，其中R1是可选择取代的芳基或可选择取代的杂环基；R2是可选择取代的C1-6烷基、C3-7环烷基等；R3是氢原子、C1-6烷基、羟基等；R4是氢原子、C1-6烷基等；R5和R6分别是C1-6烷基等；R7是可选择取代的芳基或可选择取代的杂环基；X1、X2和X3分别是C1-6亚烷基等；X4和X5分别是单键、亚甲基基团等，提供其盐、溶剂合物或前药，以及含有该化合物的药物组合物，特别是一种钙受体拮抗剂和治疗骨质疏松症的药物。本发明的化合物可用作伴有异常钙稳态或骨质疏松症、甲状旁腺功能减退症、骨肉瘤、牙周病、骨折、骨关节炎、慢性类风湿关节炎、帕盖特病、体液性高钙血症、常染色体显性低钙血症等疾病的治疗药物。此外，还提供了该化合物的中间体。
• Difluoroalkylation/C–H Annulation Cascade Reaction Induced by Visible-Light Photoredox Catalysis
  作者：Jin Li、Jingzhi Chen、Wei Jiao、Guoqiang Wang、Ying Li、Xu Cheng、Guigen Li

  DOI：10.1021/acs.joc.6b01825

  日期：2016.10.21

  report the first example of difluoroalkylation/C–H annulation cascade reactions of cyclopropyl olefins induced by visible-light photoredox catalysis regioselectively affording partially hydrogenated naphthalenes and quinolines with a variety of difluorinated side chains. The alkylation reagent could be extended to monofluoro and trifluoro reagents, nitrile and malonate. The regioselectivity was investigated

  我们报道了由可见光光氧化还原催化区域选择性地提供部分氢化的萘和喹啉以及各种二氟侧链的环丙基烯烃的二氟烷基化/ CH环合级联反应的第一个例子。烷基化试剂可扩展至单氟和三氟试剂，腈和丙二酸酯。通过密度泛函理论计算研究了区域选择性。
• Calcium receptor antagonists
  申请人：Shinagawa Yuko

  公开号：US20050107448A1

  公开（公告）日：2005-05-19

  A compound of the formula [I] wherein R 1 is optionally substituted aryl group or optionally substituted heteroaryl group; R 2 is optionally substituted C 1-6 alkyl group, C 3-7 cycloalkyl group and the like; R 3 is hydrogen atom, C 1-6 alkyl group, hydroxyl group and the like; R 4 is hydrogen atom, C 1-6 alkyl group and the like; R 5 and R 6 are each C 1-6 alkyl group and the like; R 7 is optionally substituted aryl group or optionally substituted heteroaryl group; X 1 , X 2 and X 3 are each C 1-6 alkylene group and the like; and X 4 and X 5 are each a single bond, methylene group and the like, a salt thereof, a solvate thereof or a prodrug thereof, and a pharmaceutical composition containing the compound, particularly a calcium receptor antagonist and a therapeutic agent for osteoporosis, are provided. The compound of the present invention is useful as a therapeutic drug of diseases accompanied by abnormal calcium homeostasis, or osteoporosis, hypoparathyreosis, osteosarcoma, periodontal disease, bone fracture, steoarthrosis, chronic rheumatoid arthritis, Paget's disease, humoral hypercalcemia, autosomal dominant hypocalcemia and the like. In addition, an intermediate for the compound is provided.

  本发明提供了式[I]的化合物，其中R1是可选取代芳基或可选取代杂环基；R2是可选取代C1-6烷基、C3-7环烷基等；R3是氢原子、C1-6烷基、羟基等；R4是氢原子、C1-6烷基等；R5和R6分别是C1-6烷基等；R7是可选取代芳基或可选取代杂环基；X1、X2和X3分别是C1-6亚烷基等；X4和X5分别是单键、亚甲基等。本发明还提供了该化合物的盐、溶剂化物或前药，以及包含该化合物的药物组合物，特别是钙受体拮抗剂和治疗骨质疏松症的药物。本发明的化合物可用作伴随异常钙稳态或骨质疏松症、低副甲状腺素血症、骨肉瘤、牙周病、骨折、骨关节炎、慢性类风湿性关节炎、帕盖特病、体液性高钙血症、常染色体显性低钙血症等疾病的治疗药物。此外，还提供了该化合物的中间体。
• Palladium-catalyzed stereoselective ring-opening reaction of aryl cyclopropyl ketones
  作者：Yan-Zuo Chen、Neng Wang、Zong-Rui Hou、Xian-Li Zhou、Xiaohuan Li、Feng Gao、Ting Jiang

  DOI：10.1039/d2ob00719c

  日期：——

  β-unsaturated ketones could be obtained by palladium-catalyzed ring-opening of mono-substituted cyclopropyl ketones efficiently and systematically. (E)-1-Arylbut-2-en-1-ones were generated from aryl cyclopropyl ketones stereoselectively in yields of 23–89% by the Pd(OAc)2/PCy3 catalytic system. The reaction exhibited stereoselectivity (only E products were found) and was suitable for both phenyl and

  在此，我们报道通过钯催化的单取代环丙基酮的开环可以有效且系统地获得α,β-不饱和酮。( E )-1-Arylbut-2-en-1-ones 通过 Pd(OAc) 2 /PCy 3催化体系由芳基环丙基酮立体选择性生成，收率为 23-89% 。该反应表现出立体选择性（仅发现E产物）并且适用于苯基和杂芳基环丙基酮。
• Rh(II)-Catalyzed Ring Expansion of Cyclopropyl N-Tosylhydrazones to 1-Substituted Cyclobutenes
  作者：Jingfeng Huo、Jianbo Wang、Wenbai Ouyang

  DOI：10.1055/a-1995-5960

  日期：——

  useful synthetic intermediates as well as important motifs in functional molecules. Herein, we report a straightforward access toward monosubstituted cyclobutenes from cyclopropyl N-tosylhydrazone. 1,2-Aryl or -alkyl shift of the Rh(II) carbene intermediate plays the key role in this transformation.

  环丁烯是非常有用的合成中间体，也是功能分子中的重要基序。在此，我们报告了从环丙基N-甲苯磺酰腙直接获得单取代环丁烯的方法。Rh(II) 卡宾中间体的 1,2-芳基或 - 烷基转移在这种转化中起着关键作用。